These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
257 related articles for article (PubMed ID: 8192531)
1. Human recombinant erythropoietin: progress in clinical development. Kubiak W; Karwacki M; Mazur I Ann Univ Mariae Curie Sklodowska Med; 1994; 48 Suppl 3():39-50. PubMed ID: 8192531 [No Abstract] [Full Text] [Related]
2. The use of recombinant human erythropoietin [rHuEpo] in man. Adamson JW; Eschbach JW Prog Clin Biol Res; 1990; 352():505-17. PubMed ID: 2205875 [No Abstract] [Full Text] [Related]
3. The use of recombinant human erythropoietin (rHuEpo) in humans. Adamson JW; Eschbach JW Cancer Surv; 1990; 9(1):157-67. PubMed ID: 2276112 [TBL] [Abstract][Full Text] [Related]
4. [Resistance to rHuEPO]. Sułowicz W Przegl Lek; 1995; 52(3):88-9. PubMed ID: 7644681 [No Abstract] [Full Text] [Related]
5. Erythropoietin for anemia. Med Lett Drugs Ther; 1989 Sep; 31(801):85-6. PubMed ID: 2671624 [No Abstract] [Full Text] [Related]
6. Recombinant human erythropoietin therapy in the surgical setting and applications in oncology. Goodnough LT Am J Kidney Dis; 1991 Oct; 18(4 Suppl 1):98-102. PubMed ID: 1928088 [TBL] [Abstract][Full Text] [Related]
8. Analysis of initial resistance of erythropoiesis to treatment with recombinant human erythropoietin. Results of a multicenter trial in patients with end-stage renal disease. Kühn K; Nonnast-Daniel B; Grützmacher P; Grüner J; Pfåffl W; Baldamus CA; Scigalla P Contrib Nephrol; 1988; 66():94-103. PubMed ID: 3292152 [No Abstract] [Full Text] [Related]
9. Dose-related effects of recombinant human erythropoietin on erythropoiesis. Results of a multicenter trial in patients with end-stage renal disease. Bommer J; Kugel M; Schoeppe W; Brunkhorst R; Samtleben W; Bramsiepe P; Scigalla P Contrib Nephrol; 1988; 66():85-93. PubMed ID: 3292151 [No Abstract] [Full Text] [Related]
10. Effect of erythropoietin treatment on O2 affinity and performance in patients with renal anemia. Böcker A; Reimers E; Nonnast-Daniel B; Kühn K; Koch KM; Scigalla P; Braumann KM; Brunkhorst R; Böning D Contrib Nephrol; 1988; 66():165-75. PubMed ID: 3391031 [No Abstract] [Full Text] [Related]
11. Recombinant human erythropoietin treatment of anemic cancer patients. Henry DH Cancer Pract; 1996; 4(4):180-4. PubMed ID: 8900758 [TBL] [Abstract][Full Text] [Related]
12. Serial estimation of serum interleukin 6 during treatment with recombinant human erythropoietin in patients with the anemia of rheumatoid arthritis. Jongen-Lavrencic M; Swaak AJ; Vreugdenhil G J Rheumatol; 1993 Jul; 20(7):1253-5. PubMed ID: 8371234 [No Abstract] [Full Text] [Related]
13. Side effects of erythropoietin therapy. Bennett WM Am J Kidney Dis; 1991 Oct; 18(4 Suppl 1):84-6. PubMed ID: 1928085 [TBL] [Abstract][Full Text] [Related]
15. Recombinant human erythropoietin treatment: investigational new drug protocol for the anemia of the acquired immunodeficiency syndrome. Overall results. Phair JP; Abels RI; McNeill MV; Sullivan DJ Arch Intern Med; 1993 Dec; 153(23):2669-75. PubMed ID: 8250662 [TBL] [Abstract][Full Text] [Related]